IL67085A - Tetrapeptides,a process for manufacturing them and pharmaceutical compositions containing them - Google Patents

Tetrapeptides,a process for manufacturing them and pharmaceutical compositions containing them

Info

Publication number
IL67085A
IL67085A IL67085A IL6708582A IL67085A IL 67085 A IL67085 A IL 67085A IL 67085 A IL67085 A IL 67085A IL 6708582 A IL6708582 A IL 6708582A IL 67085 A IL67085 A IL 67085A
Authority
IL
Israel
Prior art keywords
tetrapeptides
manufacturing
pharmaceutical compositions
compositions containing
pharmaceutical
Prior art date
Application number
IL67085A
Other languages
English (en)
Other versions
IL67085A0 (en
Original Assignee
Nippon Zoki Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP56172515A external-priority patent/JPS5872549A/ja
Priority claimed from JP57160138A external-priority patent/JPS5951249A/ja
Application filed by Nippon Zoki Pharmaceutical Co filed Critical Nippon Zoki Pharmaceutical Co
Publication of IL67085A0 publication Critical patent/IL67085A0/xx
Publication of IL67085A publication Critical patent/IL67085A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C5/00—Preparation of hydrocarbons from hydrocarbons containing the same number of carbon atoms
    • C07C5/02—Preparation of hydrocarbons from hydrocarbons containing the same number of carbon atoms by hydrogenation
    • C07C5/10—Preparation of hydrocarbons from hydrocarbons containing the same number of carbon atoms by hydrogenation of aromatic six-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/101—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/02—Halogenated hydrocarbons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1008—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL67085A 1981-10-28 1982-10-27 Tetrapeptides,a process for manufacturing them and pharmaceutical compositions containing them IL67085A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP56172515A JPS5872549A (ja) 1981-10-28 1981-10-28 新規ペプチド類
JP57160138A JPS5951249A (ja) 1982-09-14 1982-09-14 新規ペプチド化合物、その製法及び該化合物を含有する医薬組成物

Publications (2)

Publication Number Publication Date
IL67085A0 IL67085A0 (en) 1983-02-23
IL67085A true IL67085A (en) 1986-04-29

Family

ID=26486725

Family Applications (1)

Application Number Title Priority Date Filing Date
IL67085A IL67085A (en) 1981-10-28 1982-10-27 Tetrapeptides,a process for manufacturing them and pharmaceutical compositions containing them

Country Status (11)

Country Link
US (1) US4461724A (xx)
EP (1) EP0078228B1 (xx)
KR (1) KR900002560B1 (xx)
AU (1) AU558454B2 (xx)
BR (1) BR8206268A (xx)
CA (1) CA1248699A (xx)
DE (1) DE3275297D1 (xx)
DK (1) DK476682A (xx)
ES (1) ES8402559A1 (xx)
IL (1) IL67085A (xx)
NZ (1) NZ202297A (xx)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5177061A (en) * 1985-02-08 1993-01-05 Procyte Corporation Method for stimulating hair growth using GHL-Cu complexes
US4810693A (en) * 1985-02-08 1989-03-07 Procyte Corporation Method for inducing biological coverings in wounds
US5120831A (en) * 1985-02-08 1992-06-09 Procyte Corporation Metal-peptide compositions
ZA877535B (en) * 1986-10-09 1988-04-11 F. Hoffmann-La Roche & Co. Aktiengesellschaft Factor ix-peptides
US5145838A (en) * 1989-08-30 1992-09-08 Procyte Corporation Methods and compositions for healing ulcers
US5023237A (en) * 1989-08-30 1991-06-11 Procyte Corporation Methods and compositions for healing ulcers
US5059588A (en) * 1989-10-13 1991-10-22 Procyte Corporation, Incorporated Methods and compositions for healing bone using gly his lys: copper
US5118665A (en) * 1990-02-09 1992-06-02 Procyte Corporation Anti-oxidative and anti-inflammatory metal:peptide complexes and uses thereof
US5164367A (en) * 1990-03-26 1992-11-17 Procyte Corporation Method of using copper(ii) containing compounds to accelerate wound healing
US5776892A (en) * 1990-12-21 1998-07-07 Curative Health Services, Inc. Anti-inflammatory peptides
ATE192646T1 (de) * 1992-01-21 2000-05-15 Howard Alliger Verwendung eines stoffgemisches enthaltend alpha hydroxy organische säure zur herstellung eines arzneimittels zur behandlung von kleinen mundgeschwüren
US5382431A (en) * 1992-09-29 1995-01-17 Skin Biology, Inc. Tissue protective and regenerative compositions
US5888522A (en) * 1996-08-23 1999-03-30 Skin Biology, Inc. Tissue protective and regenerative compositions
CA2385551A1 (en) 1999-10-01 2001-04-12 Dmi Biosciences, Inc. Metal-binding compounds and uses therefor
US7632803B2 (en) * 1999-10-01 2009-12-15 Dmi Life Sciences, Inc. Metal-binding compounds and uses therefor
US7592304B2 (en) 1999-10-01 2009-09-22 Dmi Life Sciences, Inc. Metal-binding compounds and uses therefor
US20030158111A1 (en) * 1999-10-01 2003-08-21 David Bar-Or Methods and products for oral care
US20030130185A1 (en) * 2000-09-29 2003-07-10 David Bar-Or Metal-binding compounds and uses therefor
EP1417055A4 (en) * 2001-07-19 2007-09-26 Dmi Biosciences Inc USE OF COPPER CHELATORS TO PREVENT THE INACTIVATION OF PROTEIN C
WO2003043518A2 (en) * 2001-11-20 2003-05-30 Dmi Biosciences, Inc. Methods and products for oral care
WO2004000042A2 (en) * 2002-06-19 2003-12-31 N.V. Nutricia Method and composition for treating or preventing catabolism or stimulating anabolism in a mammal undergoing metabolic stress
US7217794B2 (en) * 2003-04-02 2007-05-15 Daiamed, Inc. Compounds and methods for treatment of thrombosis
BRPI0410505A (pt) * 2003-05-07 2006-06-20 Dmi Biosciences Inc métodos e produtos para cuidados orais
JP2007523908A (ja) * 2004-02-17 2007-08-23 ダイナミス セラピューティクス インコーポレイテッド フルクトサミン３キナーゼ並びにコラーゲン及びエラスチンの形成
WO2005108463A2 (en) 2004-05-03 2005-11-17 Nektar Therapeutics Al, Corporation Branched polyethylen glycol derivates comprising an acetal or ketal branching point
US20110171312A1 (en) * 2008-09-19 2011-07-14 Nektar Therapeutics Modified therapeutic peptides, methods of their preparation and use
EP2350118B1 (en) 2008-09-19 2016-03-30 Nektar Therapeutics Carbohydrate-based drug delivery polymers and conjugates thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4171299A (en) * 1975-04-04 1979-10-16 The Regents Of The University Of California Polypeptide agents for blocking the human allergic response

Also Published As

Publication number Publication date
CA1248699A (en) 1989-01-10
KR900002560B1 (ko) 1990-04-20
DK476682A (da) 1983-04-29
NZ202297A (en) 1985-08-30
ES516866A0 (es) 1984-02-01
EP0078228B1 (en) 1987-01-28
BR8206268A (pt) 1983-09-20
KR840001949A (ko) 1984-06-07
US4461724A (en) 1984-07-24
DE3275297D1 (en) 1987-03-05
EP0078228A1 (en) 1983-05-04
ES8402559A1 (es) 1984-02-01
IL67085A0 (en) 1983-02-23
AU8979082A (en) 1983-05-05
AU558454B2 (en) 1987-01-29

Similar Documents

Publication Publication Date Title
IL67085A (en) Tetrapeptides,a process for manufacturing them and pharmaceutical compositions containing them
DE3263633D1 (en) Imidazodiazepines, process for their preparation and pharmaceutical compositions containing them
PH25637A (en) Dipyridamole-containing pharmaceutical form
IL65167A0 (en) N-acyl-polypeptides,their production and pharmaceutical compositions containing them
ZA858867B (en) Tricyclo compounds,a process for their production and a pharmaceutical composition containing the same
DE3571549D1 (en) Pharmaceutical composition containing a hydroxypyrone-iron complex
DE3373100D1 (en) 2-oxo-imidazolidine compounds, a process for preparing the same and a pharmaceutical composition
DE3263531D1 (en) Amine derivatives, processes for their production and pharmaceutical compositions containing them
PH24599A (en) Amonoycyllabdanes, pharmaceutical compositions and a process for the preparations thereof
IL67336A0 (en) Pharmaceutical composition containing vitamin a
ZA824052B (en) Penicillins,a process for their preparation and compositions containing them
ZA83130B (en) A pharmaceutical composition
PH18051A (en) 3,4-bis-substituted 1,2,5-oxdiazole 2-oxides,a process for their preparation,and pharmaceutical formulations containing them
DE3378315D1 (en) Amino alkylsulphonic derivatives, a process for their preparation and pharmaceutical compositions containing said derivatives
DE3275087D1 (en) Benzamide derivatives, a process for preparing the same, and pharmaceutical compositions containing the same
DE3164469D1 (en) Acylaminoquinazoline derivatives, a process for their preparation and a pharmaceutical composition containing them
GB2109332B (en) Containers for tablets
GB2109796B (en) Anorexigenic tripeptides, process for the preparation thereof and pharmaceutical compositions containing them
IL64907A (en) Pyrrolobenzodiazepinones,a process for their preparation,their use,and medicaments containing them
ZA823919B (en) Diazepin-10-ones,processes for their preparation,and pharmaceutical compositions thereof
IL65368A0 (en) Mercapto acyl-carnitines,process for their preparation and pharmaceutical compositions containing same
IL65976A0 (en) Pharmaceutical compositions comprising a d-homosteroid
DE3160364D1 (en) 6,10,14,18-tetramethyl-5,9,13,17-nonadecatetraene-2-ol, a process for producing same and a pharmaceutical composition
DE3264212D1 (en) Phosphorus-containing oligopeptides, processes for preparation thereof and a pharmaceutical composition containing the same
GB2096990B (en) Imidazole derivatives a process for the preparation thereof and pharmaceutical compositions containing them